SAFB1 interacts with and suppresses the transcriptional activity of p53

[1]  C. Lenz,et al.  The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells. , 2010, Biochimica et biophysica acta.

[2]  H. Brauch,et al.  Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation , 2010, Proceedings of the National Academy of Sciences.

[3]  Steffi Oesterreich,et al.  SAFB1's multiple functions in biological control—lots still to be done! , 2010, Journal of cellular biochemistry.

[4]  Steffi Oesterreich,et al.  SAFB1 Mediates Repression of Immune Regulators and Apoptotic Genes in Breast Cancer Cells* , 2009, The Journal of Biological Chemistry.

[5]  E. Nikolakaki,et al.  The enzymatic activity of SR protein kinases 1 and 1a is negatively affected by interaction with scaffold attachment factors B1 and 2 , 2009, The FEBS journal.

[6]  Joonhee Han,et al.  SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. , 2009, Molecular cell.

[7]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[8]  K. Sakaguchi,et al.  SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. , 2009, Journal of molecular biology.

[9]  E. López-Bayghen,et al.  Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle. , 2008, Molecular biology of the cell.

[10]  T. Misteli.  Physiological importance of RNA and protein mobility in the cell nucleus , 2007, Histochemistry and Cell Biology.

[11]  Yun-ping Zhu,et al.  PACT is a negative regulator of p53 and essential for cell growth and embryonic development , 2007, Proceedings of the National Academy of Sciences.

[12]  A. Dejean,et al.  C-terminal modifications regulate MDM2 dissociation and nuclear export of p53 , 2007, Nature Cell Biology.

[13]  J. Venables,et al.  Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2 , 2007, Journal of Cell Science.

[14]  Adrian V. Lee,et al.  Disruption of scaffold attachment factor B1 leads to TBX2 up-regulation, lack of p19ARF induction, lack of senescence, and cell immortalization. , 2006, Cancer research.

[15]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[16]  J. Auwerx,et al.  Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. , 2005, Journal of molecular endocrinology.

[17]  Adrian V. Lee,et al.  Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain. , 2004, The Journal of biological chemistry.

[18]  R. Scott,et al.  Functional potential of P2P‐R: A role in the cell cycle and cell differentiation related to its interactions with proteins that bind to matrix associated regions of DNA? , 2003, Journal of cellular biochemistry.

[19]  Adrian V. Lee,et al.  SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor* , 2003, Journal of Biological Chemistry.

[20]  A. Traweger,et al.  The Tight Junction Protein ZO-2 Localizes to the Nucleus and Interacts with the Heterogeneous Nuclear Ribonucleoprotein Scaffold Attachment Factor-B* , 2003, The Journal of Biological Chemistry.

[21]  Ronald A. DePinho,et al.  p53: good cop/bad cop. , 2002, Cell.

[22]  A. Hartmann,et al.  Cloning and Characterization of an Alternatively Spliced Form of SR Protein Kinase 1 That Interacts Specifically with Scaffold Attachment Factor-B* , 2001, The Journal of Biological Chemistry.

[23]  J. Milner,et al.  p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress , 2001, Oncogene.

[24]  D. Woods,et al.  Regulation of p53 function. , 2001, Experimental cell research.

[25]  K. Vousden,et al.  Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .

[26]  B. Henderson,et al.  A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. , 2000, Experimental cell research.

[27]  C. Osborne,et al.  Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. , 2000, Molecular endocrinology.

[28]  G. Liu,et al.  p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE. , 1999, Biochemical and biophysical research communications.

[29]  L. Wiesmüller,et al.  Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Hartmann,et al.  SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. , 1998, Nucleic acids research.

[31]  W. Deppert,et al.  High affinity MAR‐DNA binding is a common property of murine and human mutant p53 , 1998, Journal of cellular biochemistry.

[32]  R. Scott,et al.  The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[34]  V. Rotter,et al.  PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb , 1997, Oncogene.

[35]  F. O. Fackelmayer,et al.  Purification and molecular cloning of the scaffold attachment factor B (SAF-B), a novel human nuclear protein that specifically binds to S/MAR-DNA. , 1996, Nucleic acids research.

[36]  T. Boulikas,et al.  Chromatin domains and prediction of MAR sequences. , 1995, International review of cytology.

[37]  H. Horstmann,et al.  Regulated docking of nuclear membrane vesicles to vimentin filaments during mitosis , 1993, The Journal of cell biology.

[38]  P. Cardot,et al.  Identification of a cis-acting negative DNA element which modulates human hepatic triglyceride lipase gene expression. , 1993, Biochemistry.

[39]  R. Metcalf,et al.  p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. , 1993, Carcinogenesis.

[40]  K. Isselbacher,et al.  Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. Deppert,et al.  Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells , 1986, Molecular and cellular biology.